SonALAsense

Berkeley, United States

SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.

$46.0M raised

Dec 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has SonALAsense raised?

SonALAsense has raised $46.0M in total funding. The most recent round was Grant. The last funding was announced in December 2024.

Who are SonALAsense's investors?

SonALAsense's investors include Advanced Research Projects Agency for Health, Keiretsu Forum, K4 Forum Mumbai Network.

Where is SonALAsense headquartered?

SonALAsense is headquartered in Berkeley, United States.

What does SonALAsense do?

SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.

What stage is SonALAsense at?

SonALAsense is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 12, 2024.

MLA

"SonALAsense — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/sonalasense. Accessed July 2, 2026.

APA

VCBacked. (2024). SonALAsense — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sonalasense

Wikipedia (cite web)

{{cite web |title=SonALAsense — Funding & Investors |url=https://www.vcbacked.co/company/sonalasense |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 12, 2024.